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Edited by Beat ImhofAbstract The exact phenotype and lineage of endothelial pro-
genitor cells (EPCs) are still a matter of debate and diﬀerent
expansion protocols are used to obtain them. In this study,
EPC expansion from peripheral blood mononuclear cells was
analyzed within the ﬁrst week of culture. Both the adherent
and suspended cells, of which the latter usually discarded, were
considered. We provide, for the ﬁrst time, a systematic study
of EPC phenotype and functional features within the ﬁrst 3 days
of culture. Moreover, within the 2nd day, both cellular fractions
displayed a signiﬁcant increase in endothelial marker expression
which correlated with EPC properties.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Because circulating endothelial progenitor cells (EPCs) can
contribute to postnatal vasculogenesis [1,2], preclinical and
clinical research has focused on the potential of these cells.
Several groups have developed ex vivo EPC expansion proto-
cols. EPCs have been isolated from adult peripheral blood
mononuclear cells (PBMCs) using magnetic bead selection
against diﬀerent stem cell antigens [1,3] or by primary adher-
ence on ﬁbronectin [4]. Unselected or selected EPCs have been
cultured on ﬁbronectin and non-adherent cells discarded or
seeded again within 3–4 days; the immunophenotype of the
adherent EPCs has been assessed after a culture period of sev-
eral days to weeks [5,6]. However, the lineage and exact pheno-
type of EPCs are not yet known since substantial diﬀerences
exist in previous reports concerning isolation procedures,
EPC sources and their characterization. Despite these unre-
solved questions, infusion of ex vivo expanded EPCs derived
from PBMCs in nude mice or rats has improved neovascular-
ization in ischemia models [4] and initial pilot trials indicate
that infusion of EPCs improve the blood supply to ischemic
tissue and that this therapeutic approach is safe and feasible
[7].*Corresponding author. Fax: +39 055 427 1280.
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may have impact on the yield and functional activity of ex-
panded EPCs obtained from peripheral blood, the aim of this
study was to improve our knowledge of speciﬁc characteristics
of these cells in early stages of diﬀerentiation. Therefore, iso-
lated PBMCs were cultured in the presence of angiogenic stim-
uli for one week, and a systematic study of the phenotype and
functional properties was performed in both adherent and sus-
pended cellular fractions with particular attention to the ﬁrst
three days.2. Materials and methods
2.1. Cell culture
PBMCs were isolated by Ficoll/Paque density gradient centrifuga-
tion from healthy human peripheral blood. 5 · 106 cells were stained
immediately while remaining cells were cultured on ﬁbronectin (Sig-
ma)-coated dishes for 1, 2, 3 and 7 days in EBM-2 (Clonetics, San Die-
go) supplemented with EGM-2 MV Single-Quots and 10% FCS.
2.2. Flow cytometry analysis
An Epics XL ﬂow cytometer (Beckman Coulter) was used for all
analyses. Light scatter proﬁles were collected on the cell using two elec-
tronic gates to discriminate among diﬀerent PBMC populations.
PBMCs were labelled and analyzed on day 0 and after 1, 2, 3 and 7
days of culture. At every time-point adherent and suspended PBMCs
were separately recovered. The following ﬂuorescent antibodies were
used: PECAM-1-FITC and aVb3 (BD-PharMingen; San Diego, CA),
VE-cadherin-FITC and CD45-FITC (Chemicon; Temecula, CA),
VEGF-R2-PE (R&D Systems, Minneapolis, MN), CD14-PE (Santa
Cruz; Santa Cruz, CA). Results were expressed as percent positive
cells. Isotype-identical antibodies served as controls and dead cells
were excluded by 7-ADD. Each analysis included 100000 events.
The mean ﬂuorescence intensity (MFI) > 2 was considered positive.
2.3. Immunostaining
Cells were incubated with DiI–acLDL (Molecular Probes, Leiden,
The Netherlands) and after ﬁxation with FITC-UEA-1 (VECTOR
Laboratories, Peterborough, England). Samples were viewed with an
inverted ﬂuorescent microscope [5].
2.4. RT-PCR analysis
Total RNA was extracted using Purescript RNA isolation kit (Gen-
tra, Minneapolis, MN). RT-PCR was performed using 1 lg of total
RNA. Primers for ampliﬁcation: VEGF-R2, sense-5 0-AgACTTT-
gAGCATggAAg-30, antisense-50-CCATTCCACCAAAAgATg-30; VE-
Cadherin sense-50-AAgACATCAATgACAACTTCC-3 0, antisense-
5 0-CCTCCACAgTCAggTTATACC-30 [9]; vWF sense-50-gAggCTg-
AgTTTgAAgTgC-3 0, antisense-5 0-CTgCTCCAgCTCATCCAC-3 0 [9];
PECAM-1 sense-50-CAACgAGAAAATgTCAgA-3 0, antisense-50-
ggAgCCTTCCgTTCTAgAgT-3 0 [10]; GAPDH sense-50-CCATggA-
gAAggCTgggg-3 0, antisense-5 0-CAAAgTTgTCATggATgACC-3 0 [11].blished by Elsevier B.V. All rights reserved.
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(23 cycles), annealing at 56 C; VE-Cadherin (40 cycles) and vWF
(23 cycles) annealing at 60 C. Quantitative evaluation was obtained
as ratios between optical density of the target genes and GAPDH
ampliﬁcation products.
2.5. Migration assay
A modiﬁed Boyden chamber (48-well plates; Neuroprobe) was used
as previously described [8]. Adherent and suspended cells (5 · 104),
cultured for 2 and 3 days, were seeded in the upper wells of the
chamber; SDF-1a (10 ng/ml) and VEGF (50 ng/ml) were added to
lower wells. After 5 h at 37 C, migrated cells were methanol-ﬁxed,
stained with Diﬀ-Quick and counted by microscopic evaluation
(400·) in 10 random ﬁelds. Each experimental point was measured
in triplicate.2.6. Matrigel tubule assay
Twenty-four-well multidishes were coated with growth factor-
reduced Matrigel (50 ll/cm2, BD-PharMingen; San Diego, CA)
according to the manufacturers instructions. Suspended and adherent
(6.5 · 105) plated cells were suspended in EBM-2 and incubated at
37 C. Network formation was observed using a phase contrast micro-
scope. Human umbilical vein endothelial cells (HUVEC) were used as
positive control.
2.7. Statistical evaluation
Data are reported as means ± S.E.M. Statistical analysis was per-
formed using the ANOVA test (Bonferronis and Dunnetts Multiple
Comparison Test). P < 0.05 was considered signiﬁcant.Fig. 1. Position and identiﬁcation of PBMCs by light scatter pattern.
Representative forward and side scatter plot of PBMCs freshly isolated
(day 0) (A), after 3 (B) and 7 days (C) of culture. A gate has been set
around two diﬀerent regions containing morphologically distinct cell
populations (R1, R2). A 0: HUVEC.3. Results
3.1. Morphologic analysis of the heterogeneous PBMC
population
Flow cytometric morphological discrimination of PBMC
populations was performed using their light scatter properties
so as to identify them by their position in the light scatter plot
(Fig. 1). The forward and right angle light scatter detectors
were set so that lymphocytes and monocytes were observed
in gate R1, while gate R2 was set using HUVEC with the light
scatter characteristics of mature endothelial cells (Fig. 1A 0).
The starting population, conﬁned in R1, showed lympho-
monocytic morphology which was small and slightly granular.
After 1 day of culture, 21 ± 4% of PBMCs were adherent and
reached 33.5 ± 6.3% (P < 0.01 vs day 1, n = ;16) after 1 week,
showing that the majority of cultured PBMCs were still in sus-
pension. From day 2 to one week, a new population appeared
in R2 with a diﬀerent morphology which was large and gran-
ular (Fig. 1B). This trend was highlighted by both the adherent
and suspended cells. In gate R2, suspended cells (5%, day 1)
doubled after 3 days (P < 0.01 vs day 1, n = 16). Likewise,
the adherent cells (28.5 ± 3.45%, day 1) increased by 34% after
3 days (P < 0.05 vs day 1, n = 16).
3.2. Early endothelial marker expression in PBMCs
The immunophenotype of R1- and R2-gated cells, was selec-
tively characterized during cell diﬀerentiation in the presence
of angiogenic stimuli.
The expression of monocytic marker CD14 of suspended
fraction in R1 was 17% on day zero and decreased within
the ﬁrst 3 days (Fig. 2A). After a week there were no CD14+
suspended cells, while CD14+ expression signiﬁcantly in-
creased in R2-gated adherent PBMCs, representing 64% of
the cellular population after 3 days.In gate R1, nearly 2% of both suspended and adherent
PBMCs expressed VEGF-R2 (Fig. 2B) during one week of cul-
ture, even if a signiﬁcant diﬀerence was observed on day 2.
Conversely, this receptor was highly expressed in R2-gated
cells in which 3% of freshly isolated PBMCs expressed
VEGF-R2, a value which increased up to 50% after 2 days.
On the other hand, 40% of adherent cells expressed VEGF-
R2 on day 1 and reached the maximal expression on day 3,
which was 68%.
Nearly 5% of both suspended and adherent PBMCs were
VE-cadherin+ in gate R1 (Fig. 2C), while in R2 there was a sig-
niﬁcant and time-dependent increase in VE-cadherin expres-
sion in both cell fractions. After 3 days 38% of suspended
and 50% of adherent cells were VE-cadherin+. Multi-labeling
analysis on R2-gated cells on day 2 demonstrated that co-
expression of VEGF-R2 and VE-cadherin was displayed by
2.22 + 0.43% of suspended and 4.66 + 1.1% of adherent
PBMCs.
PECAM-1 was expressed in 34% of freshly isolated PBMCs
in R1 while it was higher in R2-PBMCs (Table 1). R2-gated
cells always expressed the highest percentage of CD31-positiv-
ity.
The adherent and suspended PBMCs were also investigated
for the expression of integrin aVb3. In our culture conditions
this integrin was not expressed in suspended or in adherent
PBMCs.
The leukocyte marker CD45 was always highly expressed by
all gated cells (70–80%) in both suspended or adherent PBMCs
(data not shown).
Fig. 2. PBMC immunophenotype. Expression, in R1 and R2, of CD14 (A), VEGFR-2 (B) and VE-cadherin (C) in both suspended and adherent
PBMCs from day 0 to 1 week of culture. Means ± S.E.M. percentage of positive cells contained in each gate. \P < 0.05; \\P < 0.01; \\\P < 0.001 for
adherent cells vs day 1 (n = 11). P < 0.05; P < 0.01 for suspended cells vs day 0 (n = 11).
Table 1
Expression of PECAM-1 in cultured PBMCs
Day R1 R2
Non-adherent Adherent Non-adherent Adherent
0 34.35 ± 7.46 / 60.83 ± 8.64a /
3 16.00 ± 6.99 12.29 ± 5.58 51.68 ± 7.25a 57.61 ± 7.33b
7 16.74 ± 5.77 4.63 ± 1.63 41.74 ± 7.36a 58.32 ± 5.97b
PECAM-1 expression, in gates R1 and R2, in both adherent and non-
adherent PBMCs.
aP < 0.001 vs non-adherent fraction in R1 (n = 11).
bP < 0.001 vs adherent R1-fraction (n = 11).
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showed only UEA-1 positivity, while at day 2 also a weak
capacity to take up acLDL appeared. After 3 days cells were
strongly positive for both markers (Fig. 3). The same analysis
was performed on suspended cells in which 1.9 ± 0.5% of R2-
gated cells were UEA-1+/acLDL+ on day one, reaching10.9 ± 1.3% of positivity after 3 days (P < 0.001 vs day 1,
n = 7).
3.3. Gene expression of endothelial markers
Fig. 4 shows temporal expression of VEGF-R2, VE-cad-
herin, PECAM-1 and vWF mRNA in the ﬁrst 3 days of cul-
ture. RT-PCR was performed in the whole suspended and
adherent PBMCs without morphological discrimination of
the two fractions. VEGF-R2 mRNA expression on adherent
PBMCs signiﬁcantly increased on days 2 and 3 compared with
day 1. Likewise the expression of VE-cadherin mRNA signiﬁ-
cantly increased on days 2, only in the adherent PBMCs.
PECAM-1 and vWF genes did not seem modulated in a time-
dependent manner, either in adherent or suspended PBMCs.
3.4. Migration of adherent and suspended PBMCs
After 2 days of culture, the ability of suspended and adher-
ent PBMCs to respond to chemotactic factors was assessed by
using SDF-1a and VEGF. Both the stimuli induced signiﬁcant
Fig. 3. EPC characterization by immunoﬂuorescence. (A) Phase
contrast picture. (B) Endocytosis of acLDL. (C) Binding to EUA.
Magniﬁcation 400·.
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(Fig. 5). Moreover, VEGF induced a twofold increase in cell
migration in suspended and adherent PBMCs. Similar ﬁndings
were obtained using the cells after 3 days of culture in the pres-
ence of angiogenic stimuli.
3.5. Matrigel tubule assay
AMatrigel tubule assay was performed to assess the ability
of adherent and suspended PBMCs to form cord and tubular-
like structures. After 2 days of culture the two cellular frac-
tions were separately seeded on basement matrix gel. After a
few days of culture the formation of cord and tubular-like
structures was observed in adherent cells (Fig. 6A and B).
The suspended PBMCs had similar behaviour with a slower
kinetic (Fig. 6C and D).4. Discussion
Despite the controversy concerning the identiﬁcation and
origin of EPCs circulating in peripheral blood, ex vivo expan-
sion of these cells is widely used in most experimental studies
and clinical trials. Parallelly, several groups have identiﬁed dif-
ferent sources which can gave rise to EPCs in peripheral blood
[3,9]. Nevertheless a systematic description of phenotypic and
functional changes occurring in the heterogeneous PBMC pop-
ulations during the early stages of diﬀerentiation would be rel-
evant and of interest for both basic research and clinical
applications.In this study, early diﬀerentiation of human PBMCs into
EPCs under angiogenic conditions, was evaluated by ﬂow
cytometry analysis, which allows the simultaneous determina-
tion of both cell diﬀerentiation and cellular morphology. In
this technique the shift of cellular light scatter properties rep-
resents a very sensitive indicator for changes in cell size and
complexity. Cultured PBMCs displayed, between the 2nd
and 3rd day, a shift in their light scatter properties moving
from gate R1 to gate R2, thus suggesting that the shift dis-
played by PBMCs can be interpreted as the sequential acquisi-
tion of mature endothelial cell morphology.
The selective immunophenotype analysis of the cells gated in
R1 and R2 conﬁrmed the initial hypothesis. After two days of
culture, R2-gated cells showed 50% more expression of both
VEGF-R2 and VE-cadherin, 50% of cells were still CD14+
and more than 70% were PECAM-1+ and CD45+. It is remark-
able that only 2 days of culture were required to signiﬁcantly
change the immunophenotype on both suspended and adher-
ent PBMCs. However, VEGF-R2 expression decreased in both
non-adherent and adherent cells after 1 week of culture. This
observation, which is in contrast with some previous ﬁndings
[4] and in line with others [1], again demonstrates the tight cor-
relation between EPC source, phenotype and culture condi-
tions. It may be noted that 3-days cultured PBMCs were still
CD14+ and CD45+ supporting the knowledge that EPCs share
an endothelial and leukocyte phenotype [10].
Owing to the pivotal role of aVb3 integrin in angiogenesis its
expression was investigated on PBMCs. In the early stages of
diﬀerentiation PBMCs did not express aVb3. It seems that this
molecule is expressed in EPCs after 14 days of culture (11).
The EPC phenotype on day 3 was further conﬁrmed by
strong positivity for UEA-1 and acLDL displayed by 90% of
adherent PBMCs and by a fourfold increase of UEA-1+/
acLDL+ suspended cells.
Flow cytometry analysis and immunostaining suggested that
endothelial commitment of PBMCs may occur earlier than
generally expected, so gene expression of endothelial markers
was also investigated by RT-PCR. Both VEGF-R2 and VE-
cadherin mRNA expression on 2 days-cultured adherent
PBMCs increased signiﬁcantly and was higher than in sus-
pended cells. Probably slight diﬀerences in the expression of
PECAM-1 and vWF were not detectable because suspended
and adherent PBMCs fractions were considered without dis-
criminating between R1 and R2 gates by RT-PCR analysis.
In summary, these results may provide a molecular explana-
tion for the detection of VEGF-R2 and VE-cadherin cell sur-
face expression on PBMCs and are in line with
cytoﬂuorimetric analysis which shows their expression already
on day 2.
To determine a relationship between ﬂow cytometry immu-
nophenotype analysis of PBMCs and their functional charac-
teristic, we assessed the migration of either suspended or
adherent PBMCs, previously grown for 2 days, in response
to SDF-1a and VEGF. The former is a chemokine involved
in hematopoietic stem cell grafting in bone marrow [12], the
latter is an angiogenic factor upregulated during ischemia
and an EPC chemoattractant [11]. Both cellular fractions were
able to signiﬁcantly respond to the stimuli. Moreover the num-
ber of adherent cells involved in migration appeared to be
greater than the suspended one, thus supporting a more ad-
vanced endothelial commitment as suggested by immunophe-
notype. This was further demonstrated by the ability of
Fig. 4. Endothelial gene expression in PBMCs. PBMCs were analyzed for the expression of VEGFR-2 (A), VE-cadherin (B), PECAM-1 (C) and
vWF (D) mRNAs in the ﬁrst 3 days of culture, in both suspended and adherent cells. Data are expressed as densitometrical (OD) ratio.
Means ± S.E.M., n = 3. Figure insets: representative experiments. \P < 0.05 and \\\P < 0.001 vs adherent cells on day 1. HUVEC, positive control.
Fig. 5. Migration of 2 days-cultured PBMCs. Migration is expressed
as total counted cells/well. Means ± S.E.M., n = 3. \P < 0.05 and
\\\P < 0.001 vs control. P < 0.001 vs control.
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days of culture while the suspended cells showed a slower re-
sponse. These observations suggest that, although suspendedPBMCs display a phenotype similar to those of the adherent
cells, they still display diﬀerent cellular characteristics.
Our ﬁndings are not an attempt to characterize the pheno-
type hierarchy of EPC during in vitro culture and expansion,
but rather are a detailed and sequential description of endothe-
lial diﬀerentiation of PBMCs in an angiogenic environment
which strongly suggests that the endothelial commitment
may occur earlier than previously expected. Certainly, diﬀerent
cellular types are present in PBMCs which might contribute to
EPC expansion and support our results [9].
It is important to demonstrate the speciﬁc features of EPCs
expanded in vitro from peripheral blood in order to improve
their therapeutic use. Most recent pilot clinical trials have in-
volved infusion of EPCs isolated from peripheral blood and
cultured for 3 days. The present data provide both a quantiﬁ-
cation of PBMC populations committed to an endothelial phe-
notype in response to angiogenic stimuli, and a quantitative
evaluation of endothelial marker expression in these diﬀerent
cellular fractions. We demonstrate, for the ﬁrst time, that
PBMC cellular fraction in suspension, which is usually
Fig. 6. Network formation of 2 days-cultured PBMCs. Both Suspended and adherent PBMCs were seeded in growth factor-reduced Matrigel.
(A,B) Network formation and cord-like structures in adherent PBMCs. (C,D) Network-like structures in suspended PBMCs (200·).
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ble behaviour and may constitute a non-negligible target.Acknowledgement: Supported by the Italian Ministry of University and
Scientiﬁc and Technological Research (FIRB) to Professor F. Ledda.References
[1] Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee,
R., Li, T., Witzenbichler, B., Schatteman, G. and Isner, J.M.
(1997) Isolation of putative progenitor endothelial cells for
angiogenesis. Science 275, 964–967.
[2] Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M.,
Kearney, M., Magner, M., Isner, J.M. and Asahara, T. (1999)
Ischemia- and cytokine-induced mobilization of bone marrow-
derived endothelial progenitor cells for neovascularization. Nat.
Med. 5, 434–438.
[3] Peichev, M., Naiyer, A.J., Pereira, D., Zhu, Z., Lane, W.J.,
Williams, M., Oz, M.C., Hicklin, D.J., Witte, L., Moore,
M.A. and Raﬁi, S. (2000) Expression of VEGFR-2 and
AC133 by circulating human CD34+ cells identiﬁes a
population of functional endothelial precursors. Blood 95,
952–958.
[4] Kalka, C., Masuda, H., Takahashi, T., Kalka-Moll, W.M., Silver,
M., Kearney, M., Li, T., Isner, J.M. and Asahara, T. (2000)
Transplantation of ex vivo expanded endothelial progenitor cells
for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA
97, 3422–3427.[5] Vasa, M., Fichtlscherer, S., Aicher, A., Adler, K., Urbich, C.,
Martin, H., Zeiher, A.M. and Dimmeler, S. (2001) Number and
migratory activity of circulating endothelial progenitor cells
inversely correlate with risk factors for coronary artery disease.
Circ. Res. 89, e1–e7.
[6] Reyes, M., Dudek, A., Jahagirdar, B., Koodie, L., Marker,
P.H. and Verfaillie, C.M. (2002) Origin of endothelial
progenitors in human postnatal bone marrow. J. Clin. Invest.
109, 337–346.
[7] Scha¨chinger, V., Assmus, B., Britten, M.B., Honold, J.,
Lehmann, R., Teupe, C., Albolmaali, N.D., Vogl, T.J.,
Hofmann, W.-K., Martin, H., Dimmeler, S. and Zeiher, A.
(2004) Transplantation of progenitor cells and regeneration
enhancement in acute myocardial infarction. J. Am. Coll.
Cardiol. 44, 1690–1699.
[8] Parenti, A., Donnini, S., Morbidelli, L., Granger, H.J. and Ziche,
M. (1996) Br. J. Pharmacol. 119, 619–621.
[9] Ingram, D.A., Mead, L.E., Tanaka, H., Meade, V., Fenoglio, A.,
Mortell, K., Pollok, K., Ferkowicz, M.J., Gilley, D. and Yoder,
M.C. (2004) Blood 104, 2752–2760.
[10] Schmeisser, A., Garlichs, C.D., Zhang, H., Eskaﬁ, S., Graﬀy, C.,
Ludwig, J., Strasser, R.H. and Daniel, W.G. (2001) Monocytes
coexpress endothelial and macrophagocytic lineage markers and
form cord-like structures in Matrigel under angiogenic condi-
tions. Cardiovasc. Res. 49, 671–680.
[11] Kalka, C., Masuda, H., Takahashi, T., Gordon, R., Tepper, O.,
Gravereaux, E., Pieczek, A., Iwaguro, H., Hayashi, S.I., Isner,
J.M. and Asahara, T. (2000) Circ. Res. 86, 1198–1202.
[12] Peled, A., Grabovsky, V., Habler, L., Sandbank, J., Arenzana-
Seisdedos, F., Petit, I., Ben-Hur, H., Lapidot, T. and Alon, R.
(1999) J. Clin. Invest. 104, 1199–1211.
